论文部分内容阅读
近年来人们日益认识到癫(Ep)合并情感性精神障碍的重要性,但多数研究集中干抑郁症。然而,Ep伴发焦虑障碍十分普遍,文献报道焦虑障碍的患病率达111%~46%。有研究表明,Ep和焦虑具有双向联系,且可能有共同的病理生理基础。焦虑严重影响Ep患者的生活质量,放大抗癫药物的不良反应。尽管如此,临床上常忽略对焦虑症状的筛查。Ep患者的焦虑症状可分为仅出现于Ep发作前、中和后(围Ep发作期)的焦虑,类似原发性焦虑障碍的焦虑症,或与Ep本身或其治疗有关的焦虑。对Ep焦虑症状的治疗包括:更有效的控制Ep发作治疗围Ep发作期的焦虑,而大多数形式的焦虑发作以认知行为治疗或药物治疗为主。
In recent years, people are increasingly aware of the importance of epilepsy (Ep) combined with emotional disorders, but most studies focus on depression. Ep anxiety disorders are common, however, and the prevalence of anxiety disorders reported in the literature ranges from 111% to 46%. Studies have shown that Ep and anxiety have a two-way relationship, and may have a common pathophysiological basis. Anxiety seriously affects the quality of life of patients with Ep and amplifies the adverse reactions of antiepileptic drugs. However, screening for anxiety symptoms is often overlooked clinically. Anxiety symptoms in Ep patients can be categorized as anxiety occurring only before, during, and after Ep episodes (episodes of Peripheral Ep), anxiety like primary anxiety disorders, or anxiety associated with Ep itself or its treatment. Treatment of Ep anxiety symptoms includes: more effective control of Ep episodes of Epic episodes of Epidemic anxiety, and most forms of anxiety episodes with cognitive behavioral therapy or drug-based therapy.